Category :

Cancer/Oncology Press Releases

CogniFit Introduces a New Digital Cognitive Assessment to Provide Cancer Patients With More Support for Chemo Brain

CogniFit, a world leader in neuropsychological testing, brain training, and cognitive stimulation, has launched an online cognitive assessment battery designed to help screen cognitive impairment in cancer patients. This battery is a complete cognitive screening to assess the risk index…

Planet TV Presents the Innovation and Emotional Relief of Fine Needle Aspiration Evaluations Performed at the Clinic of Dr. Idalia Santaella in Florida

"New Frontiers" has created a new medical TV series debuting Miami’s Fine Needle Aspiration Clinic directed under the compassionate and highly educated guidance of pathologist, Dr. Idalia Santaella. The clinic removes a tremendous source of anxiety from patients facing a…

HistoGeneX PD-L1 IHC and CD8 Work in ABACUS Trial Presented at ASCO 2018

Abacus Trial presented at ASCO 2018: Neo-adjuvant immunotherapy in bladder cancer. Complete pathological response in bladder wall is related with the PDL1 status and opens opportunities to understand biological mechanism of action. Thomas Powles (MD, Barts Cancer Institute, Queen Mary…

Organic Soup Kitchen Launches Cancer Recovery Hub

​Organic Soup Kitchen, a 501(c)3 located in Santa Barbara, California, is announcing a one-year capital campaign that will seek to raise $1.5 million. The proceeds will fund a 3,000-square-foot nutrient therapy for cancer patients headquarters, an endowment and sustain five years…

FCS Research to Be Published at American Society of Clinical Oncology's Annual Meeting

Florida Cancer Specialists & Research Institute (FCS) is pleased to announce that there are a record 36 research studies co-authored by FCS physicians that will be published and/or presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held…

Akoya Biosciences Announces Full Enrollment in the CODEX™ Early Access Program for Highly Multiplexed Tissue Analysis

​​Akoya Biosciences today announced that the CODEX™ Early Access Program to provide a comprehensive solution for spatially resolved, highly multiplexed biomarker analysis is fully enrolled and underway. Ten sites purchased the CODEX Early Access Platform, comprised of a fluidics-based instrument,…

The Employers Centers of Excellence Network Expanding to Include 'Best of Both' Cancer Care

The Employers Centers of Excellence Network (ECEN), a partnership between the Pacific Business Group on Health (PBGH) and Health Design Plus (HDP), announced today that it is expanding to include cancer care. The ECEN oncology program is designed to create…

Florida Cancer Specialists & Research Institute Announces New Cancer Center in Ocala

On May 16, 2018, at 8:00 a.m., Florida Cancer Specialists (FCS) celebrated a new state-of-the-art cancer center that will be located on SW 48th Ave (off SR 200), Ocala, Florida 34474. With shovels in hand, FCS Executive Management, staff and Marion County…

Young Lung Cancer Investigators Awarded $200K to Improve Lung Cancer Outcomes

Lung Cancer Foundation of America (LCFA) and the International Association for the Study of Lung Cancer (IASLC) have awarded a pair of two-year grants, generously funded in part by Bristol-Myers Squibb, to support research that will hopefully help lung cancer patients…

Flow Cytometry-Based Tools to Enrich Your Preclinical Immuno-Oncology Research, New Webinar Hosted by Xtalks

In a live broadcast upcoming on Wednesday, May 16, 2018, at 1 p.m. EDT, industry experts from MI Bioresearch Dylan Daniel, Ph.D., director of scientific development, and David Draper, Ph.D., associate director of scientific development, will describe advances in flow…

Overcoming the Challenges of Immuno-Oncology Biomarker Discovery: From Sample to Analytics, New Webinar Hosted by Xtalks

In this webinar, featured speaker Erin Newburn, Associate Director and Field Applications Scientist from Personalis, Inc. will discuss how a combined whole exome and transcriptome platform such as ACE ImmunoID™ can help to overcome obstacles of immuno-oncology biomarker discovery. Topics include: Generating…

Donor Determined to Shine Light on Cancers of the Hepatobiliary System Gives Second Donation of $10K to The Bili Project Foundation

Donor Determined to Shine Light on Cancers of the Hepatobiliary System Gives Second Donation of $10K to The Bili Project Foundation

The Bili Project Foundation has received a grant of $10,000 from one of its devoted supporters and Biliever’s, Ana Gonzalez. Ana Gonzalez, founder of the Yli Believe Foundation, contributed this grant in honor of her dear father Pedro Gonzalez. He was the loving…

Two Women Scientists Granted $400k for Promising Lung Cancer Research

Two Women Scientists Granted $400k for Promising Lung Cancer Research

Groundbreaking research into the early diagnosis of lung cancer and potential new treatments have been awarded funding through two lung cancer research-focused foundations. Lung Cancer Foundation of America (LCFA) and the International Association for the Study of Lung Cancer (IASLC)…

CytoTest Boosts Global Sales Team

CytoTest Inc., a cutting-edge molecular diagnostics company headquartered in the National Capital area, today announced the continued expansion of its sales team with the addition of representatives in three major market territories: Tomasz Czerski will act as a VP /…

Body Composition in Clinical Trials – From BMI to MRI, New Webinar Hosted by Xtalks

Body Composition in Clinical Trials – From BMI to MRI, New Webinar Hosted by Xtalks

In a live session upcoming on Tuesday, February 13, 2018 at 11 a.m. EST, experts from Biotelemetry and AMRA will discuss alternative methods to BMI for determining body composition in clinical trials. Webinar Details: Body Composition in Clinical Trials –…

CureOne Recognized by Medicare as a Leader in Quality Data Collection and Reporting

CureOne™, a nonprofit movement dedicated to standardizing next generation sequencing (NGS) and connecting it with matched clinical outcome data, has been named a Medicare Quality Clinical Data Registry (QCDR), making it the only registry of its kind to achieve this…

Addressing Platelet Refractoriness: Giving Hematology-Oncology Patients the Best Chance of Success, New Webinar Hosted by Xtalks

Addressing Platelet Refractoriness: Giving Hematology-Oncology Patients the Best Chance of Success, New Webinar Hosted by Xtalks

Join the live session on Wednesday, Jan. 24, 2018 with featured speaker Dr. Elisabeth Maurer-Spurej, Founder of LightIntegra Technology and principal inventor of ThromboLUX®. Dr. Maurer-Spurej will introduce activated platelets and their prevalence, discuss the impacts of activated platelet transfusions,…

Sci-Engi-Medco Solutions Inc. Awarded SBIR Phase 1 NCI Contract to Study Its Lead Molecules in Preclinical Model of Triple Negative Breast Cancer

​​​Sci-Engi-Medco Solutions Inc. (SEMCO), a private cancer drug discovery and development company that explores its proprietary small molecule anticancer agent technology, announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase 1 contract from the National…

Consumer Safety Watch Warns Paclitaxel Weekly More Effective, Has Fewer Side Effects Than Docetaxel for Women Diagnosed With Breast Cancer That Had Spread to the Lymph Nodes

Consumer Safety Watch Warns Paclitaxel Weekly More Effective, Has Fewer Side Effects Than Docetaxel for Women Diagnosed With Breast Cancer That Had Spread to the Lymph Nodes

A recent study concluded that treatment with paclitaxel weekly had more benefits than treatment with paclitaxel every three weeks for women diagnosed with breast cancer that had spread to the lymph nodes or women diagnosed with breast cancer that hadn't spread to the…

ImmunoBiochem Corporation Announces the Completion of a New Round of Financing and Residency at Johnson & Johnson Innovation, JLABS @ Toronto

ImmunoBiochem Corporation Announces the Completion of a New Round of Financing and Residency at Johnson & Johnson Innovation, JLABS @ Toronto

ImmunoBiochem Corporation, a Canadian biopharmaceutical company developing novel biological therapeutics, has completed a new round of financing led by angel investors and the company’s founding investor. ImmunoBiochem has also expanded its operations and is now located at Johnson & Johnson…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login